The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-11-29

AUTHORS

Karelle Leroy, Allal Boutajangout, M. Authelet, James R. Woodgett, Brian H. Anderton, Jean-Pierre Brion

ABSTRACT

. Glycogen synthase kinase-3β (GSK-3β) is a physiological kinase for tau and is a candidate protein kinase involved in the hyperphosphorylation of tau present in paired helical filament (PHF)-tau of neurofibrillary tangles (NFT) in Alzheimer's disease (AD). GSK-3β is also a key element of several signaling cascades (including cell death cascades). We have investigated the immunocytochemical localization of GSK-3 immunoreactivity in AD. Neurons exhibiting strongly GSK-3-immunoreactive granules were observed in AD, with a much higher frequency than in control subjects. This immunoreactivity was found to co-localize with the granulovacuolar degeneration (GVD) and to be associated with the granules of the granulovacuolar bodies. The GVD granules showed a strong GSK-3α and GSK-3β immunoreactivity, and this immunoreactivity was abolished by preabsorption with recombinant GSK-3. In addition, the GVD immunoreactivity was observed with an antibody against the tyrosine-phosphorylated and active form of GSK-3. Some granules of the granulovacuolar degeneration were also intensely labeled with an antibody specific for tau isoforms containing insert 1 (exon 2) and with antibodies specific for tau phosphorylated on Ser262 and for tau phosphorylated on Thr212/Ser214, two phosphorylation sites generated in vitro by GSK-3α and β. GSK-3β was expressed in neurons containing NFT but only a small proportion of intracellular NFT were observed to be GSK-3β immunoreactive. Immunoblotting analysis of fractions enriched in PHF-tau did not reveal any GSK-3β immunoreactivity in these fractions, indicating that GSK-3β was only loosely associated to NFT. These results suggest that neurons developing GVD sequester an active, potentially deleterious, form of GSK-3 in this compartment and that increased GSK-3 immunoreactivity in a subset of neurons quantitatively differentiates normal aging from AD. More... »

PAGES

91-99

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004010100435

DOI

http://dx.doi.org/10.1007/s004010100435

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048273000

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11810173


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alzheimer Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium-Calmodulin-Dependent Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycogen Synthase Kinase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycogen Synthase Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granulocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hippocampus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nerve Degeneration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parahippocampal Gyrus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vacuoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "tau Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.4989.c", 
          "name": [
            "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leroy", 
        "givenName": "Karelle", 
        "id": "sg:person.01021051532.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021051532.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.4989.c", 
          "name": [
            "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boutajangout", 
        "givenName": "Allal", 
        "id": "sg:person.01235237617.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235237617.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.4989.c", 
          "name": [
            "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Authelet", 
        "givenName": "M.", 
        "id": "sg:person.01026365317.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026365317.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415224.4", 
          "name": [
            "Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodgett", 
        "givenName": "James R.", 
        "id": "sg:person.0731233037.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK", 
          "id": "http://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Department of Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderton", 
        "givenName": "Brian H.", 
        "id": "sg:person.0715075073.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715075073.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.4989.c", 
          "name": [
            "Laboratory of Histology, Neuroanatomy and Neuropathology, Universit\u00e9 Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brion", 
        "givenName": "Jean-Pierre", 
        "id": "sg:person.010401041542.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010401041542.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00227819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001370220", 
          "https://doi.org/10.1007/bf00227819"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4684-8503-5_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013484745", 
          "https://doi.org/10.1007/978-1-4684-8503-5_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686619", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021099849", 
          "https://doi.org/10.1007/bf00686619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00230483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001981802", 
          "https://doi.org/10.1007/bf00230483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00690970", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016369234", 
          "https://doi.org/10.1007/bf00690970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00296544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050263578", 
          "https://doi.org/10.1007/bf00296544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00308809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000355620", 
          "https://doi.org/10.1007/bf00308809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00304627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019558665", 
          "https://doi.org/10.1007/bf00304627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004010050513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004834689", 
          "https://doi.org/10.1007/s004010050513"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-11-29", 
    "datePublishedReg": "2001-11-29", 
    "description": "Abstract. Glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) is a physiological kinase for tau and is a candidate protein kinase involved in the hyperphosphorylation of tau present in paired helical filament (PHF)-tau of neurofibrillary tangles (NFT) in Alzheimer's disease (AD). GSK-3\u03b2 is also a key element of several signaling cascades (including cell death cascades). We have investigated the immunocytochemical localization of GSK-3 immunoreactivity in AD. Neurons exhibiting strongly GSK-3-immunoreactive granules were observed in AD, with a much higher frequency than in control subjects. This immunoreactivity was found to co-localize with the granulovacuolar degeneration (GVD) and to be associated with the granules of the granulovacuolar bodies. The GVD granules showed a strong GSK-3\u03b1 and GSK-3\u03b2 immunoreactivity, and this immunoreactivity was abolished by preabsorption with recombinant GSK-3. In addition, the GVD immunoreactivity was observed with an antibody against the tyrosine-phosphorylated and active form of GSK-3. Some granules of the granulovacuolar degeneration were also intensely labeled with an antibody specific for tau isoforms containing insert 1 (exon 2) and with antibodies specific for tau phosphorylated on Ser262 and for tau phosphorylated on Thr212/Ser214, two phosphorylation sites generated in vitro by GSK-3\u03b1 and \u03b2. GSK-3\u03b2 was expressed in neurons containing NFT but only a small proportion of intracellular NFT were observed to be GSK-3\u03b2 immunoreactive. Immunoblotting analysis of fractions enriched in PHF-tau did not reveal any GSK-3\u03b2 immunoreactivity in these fractions, indicating that GSK-3\u03b2 was only loosely associated to NFT. These results suggest that neurons developing GVD sequester an active, potentially deleterious, form of GSK-3 in this compartment and that increased GSK-3 immunoreactivity in a subset of neurons quantitatively differentiates normal aging from AD.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s004010100435", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1019073", 
        "issn": [
          "0001-6322", 
          "1432-0533"
        ], 
        "name": "Acta Neuropathologica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "103"
      }
    ], 
    "keywords": [
      "granulovacuolar degeneration", 
      "neurofibrillary tangles", 
      "Alzheimer's disease", 
      "glycogen synthase kinase-3\u03b2", 
      "synthase kinase-3\u03b2", 
      "GSK-3\u03b2", 
      "Thr212/Ser214", 
      "kinase-3\u03b2", 
      "intracellular neurofibrillary tangles", 
      "subset of neurons", 
      "hyperphosphorylation of tau", 
      "GSK-3", 
      "GSK-3\u03b1", 
      "control subjects", 
      "granulovacuolar bodies", 
      "immunoreactivity", 
      "normal aging", 
      "PHF-tau", 
      "neurons", 
      "disease", 
      "tau isoforms", 
      "GVD granules", 
      "active form", 
      "Immunocytochemical localization", 
      "degeneration", 
      "antibodies", 
      "tau", 
      "Immunoblotting analysis", 
      "insert-1", 
      "candidate protein kinases", 
      "helical filaments", 
      "small proportion", 
      "physiological kinase", 
      "phosphorylation sites", 
      "protein kinase", 
      "high frequency", 
      "immunoreactive", 
      "granules", 
      "preabsorption", 
      "kinase", 
      "Ser262", 
      "tangles", 
      "hyperphosphorylation", 
      "subjects", 
      "isoforms", 
      "proportion", 
      "subset", 
      "compartments", 
      "Ser214", 
      "aging", 
      "cascade", 
      "fraction", 
      "localization", 
      "body", 
      "frequency", 
      "form", 
      "filaments", 
      "key elements", 
      "addition", 
      "sites", 
      "analysis", 
      "results", 
      "elements"
    ], 
    "name": "The active form of glycogen synthase kinase-3\u03b2 is associated with granulovacuolar degeneration in neurons in Alzheimer's disease", 
    "pagination": "91-99", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048273000"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004010100435"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11810173"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004010100435", 
      "https://app.dimensions.ai/details/publication/pub.1048273000"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_319.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s004010100435"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004010100435'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004010100435'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004010100435'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004010100435'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      21 PREDICATES      111 URIs      94 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004010100435 schema:about N22a6ff30bdeb4f5eb51dda84797f01eb
2 N26a029c7150a4310a91043b231ab44b5
3 N36d67bc0958946dba68a6de9ac806980
4 N3cac8e18d2d04fa782cd9c7ce906fefb
5 N57f99c03f1b340419d1269c25d3527ac
6 N5e0f99844e804db188722b96e746e149
7 N77d417bfef9d4e9b87c19a39e23ebc6e
8 N7e1e81ba6b864f86b5ea316a30d94911
9 N946ff46e5e964d91a4fe1f74edd6d4c6
10 Nb48f877109b04d9181cbf56d17f9ea13
11 Nbea068671f08447e91707bb247b0a814
12 Ndf25065569aa49b49732081213d7ba40
13 Neb7b26237af44d7eb4afcadea2dd5e3a
14 Nf24e3aedc8594fffa59e912cc1fb06e3
15 anzsrc-for:11
16 anzsrc-for:1109
17 schema:author Nbbcd6eb80ec14c698002a61ae070184b
18 schema:citation sg:pub.10.1007/978-1-4684-8503-5_7
19 sg:pub.10.1007/bf00227819
20 sg:pub.10.1007/bf00230483
21 sg:pub.10.1007/bf00296544
22 sg:pub.10.1007/bf00304627
23 sg:pub.10.1007/bf00308809
24 sg:pub.10.1007/bf00686619
25 sg:pub.10.1007/bf00690970
26 sg:pub.10.1007/s004010050513
27 schema:datePublished 2001-11-29
28 schema:datePublishedReg 2001-11-29
29 schema:description Abstract. Glycogen synthase kinase-3β (GSK-3β) is a physiological kinase for tau and is a candidate protein kinase involved in the hyperphosphorylation of tau present in paired helical filament (PHF)-tau of neurofibrillary tangles (NFT) in Alzheimer's disease (AD). GSK-3β is also a key element of several signaling cascades (including cell death cascades). We have investigated the immunocytochemical localization of GSK-3 immunoreactivity in AD. Neurons exhibiting strongly GSK-3-immunoreactive granules were observed in AD, with a much higher frequency than in control subjects. This immunoreactivity was found to co-localize with the granulovacuolar degeneration (GVD) and to be associated with the granules of the granulovacuolar bodies. The GVD granules showed a strong GSK-3α and GSK-3β immunoreactivity, and this immunoreactivity was abolished by preabsorption with recombinant GSK-3. In addition, the GVD immunoreactivity was observed with an antibody against the tyrosine-phosphorylated and active form of GSK-3. Some granules of the granulovacuolar degeneration were also intensely labeled with an antibody specific for tau isoforms containing insert 1 (exon 2) and with antibodies specific for tau phosphorylated on Ser262 and for tau phosphorylated on Thr212/Ser214, two phosphorylation sites generated in vitro by GSK-3α and β. GSK-3β was expressed in neurons containing NFT but only a small proportion of intracellular NFT were observed to be GSK-3β immunoreactive. Immunoblotting analysis of fractions enriched in PHF-tau did not reveal any GSK-3β immunoreactivity in these fractions, indicating that GSK-3β was only loosely associated to NFT. These results suggest that neurons developing GVD sequester an active, potentially deleterious, form of GSK-3 in this compartment and that increased GSK-3 immunoreactivity in a subset of neurons quantitatively differentiates normal aging from AD.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf Nea254afa1d0f4a5b8122aeff4fb2497d
33 Nea67943994284ac0b66e72eb198cb6b2
34 sg:journal.1019073
35 schema:keywords Alzheimer's disease
36 GSK-3
37 GSK-3α
38 GSK-3β
39 GVD granules
40 Immunoblotting analysis
41 Immunocytochemical localization
42 PHF-tau
43 Ser214
44 Ser262
45 Thr212/Ser214
46 active form
47 addition
48 aging
49 analysis
50 antibodies
51 body
52 candidate protein kinases
53 cascade
54 compartments
55 control subjects
56 degeneration
57 disease
58 elements
59 filaments
60 form
61 fraction
62 frequency
63 glycogen synthase kinase-3β
64 granules
65 granulovacuolar bodies
66 granulovacuolar degeneration
67 helical filaments
68 high frequency
69 hyperphosphorylation
70 hyperphosphorylation of tau
71 immunoreactive
72 immunoreactivity
73 insert-1
74 intracellular neurofibrillary tangles
75 isoforms
76 key elements
77 kinase
78 kinase-3β
79 localization
80 neurofibrillary tangles
81 neurons
82 normal aging
83 phosphorylation sites
84 physiological kinase
85 preabsorption
86 proportion
87 protein kinase
88 results
89 sites
90 small proportion
91 subjects
92 subset
93 subset of neurons
94 synthase kinase-3β
95 tangles
96 tau
97 tau isoforms
98 schema:name The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease
99 schema:pagination 91-99
100 schema:productId N2f8543cff6b6452c81a6a1d158d076ff
101 N4d00e5c902274cda9f00b2cb118a258a
102 Ndeed0fa064eb408fb27cae724c2e1f4a
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048273000
104 https://doi.org/10.1007/s004010100435
105 schema:sdDatePublished 2022-10-01T06:31
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Ncb12f23e4c954515a31f99bc436a7a1b
108 schema:url https://doi.org/10.1007/s004010100435
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N22a6ff30bdeb4f5eb51dda84797f01eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Nerve Degeneration
114 rdf:type schema:DefinedTerm
115 N22ce071007204ca7be33eea19aa468d9 rdf:first sg:person.0715075073.28
116 rdf:rest N59f51c1e514b42a799843b7ec224d1c0
117 N26a029c7150a4310a91043b231ab44b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Aged
119 rdf:type schema:DefinedTerm
120 N299c3f855cb748cb926c4c4e4b05a845 rdf:first sg:person.01235237617.09
121 rdf:rest Nb0ef8021ff35480b94bab888a6f82e7d
122 N2f8543cff6b6452c81a6a1d158d076ff schema:name dimensions_id
123 schema:value pub.1048273000
124 rdf:type schema:PropertyValue
125 N36d67bc0958946dba68a6de9ac806980 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name tau Proteins
127 rdf:type schema:DefinedTerm
128 N3cac8e18d2d04fa782cd9c7ce906fefb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Hippocampus
130 rdf:type schema:DefinedTerm
131 N4a7ff7f6cc2c48428eba99e109fa7d3f rdf:first sg:person.0731233037.88
132 rdf:rest N22ce071007204ca7be33eea19aa468d9
133 N4d00e5c902274cda9f00b2cb118a258a schema:name pubmed_id
134 schema:value 11810173
135 rdf:type schema:PropertyValue
136 N57f99c03f1b340419d1269c25d3527ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged, 80 and over
138 rdf:type schema:DefinedTerm
139 N59f51c1e514b42a799843b7ec224d1c0 rdf:first sg:person.010401041542.25
140 rdf:rest rdf:nil
141 N5e0f99844e804db188722b96e746e149 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Alzheimer Disease
143 rdf:type schema:DefinedTerm
144 N77d417bfef9d4e9b87c19a39e23ebc6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Humans
146 rdf:type schema:DefinedTerm
147 N7e1e81ba6b864f86b5ea316a30d94911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Glycogen Synthase Kinase 3
149 rdf:type schema:DefinedTerm
150 N946ff46e5e964d91a4fe1f74edd6d4c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name In Vitro Techniques
152 rdf:type schema:DefinedTerm
153 Nb0ef8021ff35480b94bab888a6f82e7d rdf:first sg:person.01026365317.29
154 rdf:rest N4a7ff7f6cc2c48428eba99e109fa7d3f
155 Nb48f877109b04d9181cbf56d17f9ea13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Parahippocampal Gyrus
157 rdf:type schema:DefinedTerm
158 Nbbcd6eb80ec14c698002a61ae070184b rdf:first sg:person.01021051532.33
159 rdf:rest N299c3f855cb748cb926c4c4e4b05a845
160 Nbea068671f08447e91707bb247b0a814 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Vacuoles
162 rdf:type schema:DefinedTerm
163 Ncb12f23e4c954515a31f99bc436a7a1b schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Ndeed0fa064eb408fb27cae724c2e1f4a schema:name doi
166 schema:value 10.1007/s004010100435
167 rdf:type schema:PropertyValue
168 Ndf25065569aa49b49732081213d7ba40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Calcium-Calmodulin-Dependent Protein Kinases
170 rdf:type schema:DefinedTerm
171 Nea254afa1d0f4a5b8122aeff4fb2497d schema:volumeNumber 103
172 rdf:type schema:PublicationVolume
173 Nea67943994284ac0b66e72eb198cb6b2 schema:issueNumber 2
174 rdf:type schema:PublicationIssue
175 Neb7b26237af44d7eb4afcadea2dd5e3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Glycogen Synthase Kinases
177 rdf:type schema:DefinedTerm
178 Nf24e3aedc8594fffa59e912cc1fb06e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Granulocytes
180 rdf:type schema:DefinedTerm
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
185 schema:name Neurosciences
186 rdf:type schema:DefinedTerm
187 sg:journal.1019073 schema:issn 0001-6322
188 1432-0533
189 schema:name Acta Neuropathologica
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01021051532.33 schema:affiliation grid-institutes:grid.4989.c
193 schema:familyName Leroy
194 schema:givenName Karelle
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021051532.33
196 rdf:type schema:Person
197 sg:person.01026365317.29 schema:affiliation grid-institutes:grid.4989.c
198 schema:familyName Authelet
199 schema:givenName M.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026365317.29
201 rdf:type schema:Person
202 sg:person.010401041542.25 schema:affiliation grid-institutes:grid.4989.c
203 schema:familyName Brion
204 schema:givenName Jean-Pierre
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010401041542.25
206 rdf:type schema:Person
207 sg:person.01235237617.09 schema:affiliation grid-institutes:grid.4989.c
208 schema:familyName Boutajangout
209 schema:givenName Allal
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235237617.09
211 rdf:type schema:Person
212 sg:person.0715075073.28 schema:affiliation grid-institutes:grid.13097.3c
213 schema:familyName Anderton
214 schema:givenName Brian H.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715075073.28
216 rdf:type schema:Person
217 sg:person.0731233037.88 schema:affiliation grid-institutes:grid.415224.4
218 schema:familyName Woodgett
219 schema:givenName James R.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88
221 rdf:type schema:Person
222 sg:pub.10.1007/978-1-4684-8503-5_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013484745
223 https://doi.org/10.1007/978-1-4684-8503-5_7
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/bf00227819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001370220
226 https://doi.org/10.1007/bf00227819
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/bf00230483 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001981802
229 https://doi.org/10.1007/bf00230483
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf00296544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050263578
232 https://doi.org/10.1007/bf00296544
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/bf00304627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019558665
235 https://doi.org/10.1007/bf00304627
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/bf00308809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000355620
238 https://doi.org/10.1007/bf00308809
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/bf00686619 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021099849
241 https://doi.org/10.1007/bf00686619
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/bf00690970 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016369234
244 https://doi.org/10.1007/bf00690970
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s004010050513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004834689
247 https://doi.org/10.1007/s004010050513
248 rdf:type schema:CreativeWork
249 grid-institutes:grid.13097.3c schema:alternateName Department of Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK
250 schema:name Department of Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK
251 rdf:type schema:Organization
252 grid-institutes:grid.415224.4 schema:alternateName Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada
253 schema:name Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada
254 rdf:type schema:Organization
255 grid-institutes:grid.4989.c schema:alternateName Laboratory of Histology, Neuroanatomy and Neuropathology, Université Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium
256 schema:name Laboratory of Histology, Neuroanatomy and Neuropathology, Université Libre de Bruxelles, School of Medicine, 808 route de Lennik, Bldg C-10, 1070 Brussels, Belgium
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...